Delcath Systems, Inc. (NASDAQ:DCTH) Q2 2022 Earnings Conference Call August 8, 2022 8:30 AM ET

Company Participants

David Hoffman - General Counsel

Gerard Michel - Chief Executive Officer

Anthony Dias - Vice President of Finance

Johnny John - Senior Vice President of Medical Affairs and Clinical Development

Kevin Muir - Vice President of Commercial Operations

John Purpura - Chief Operating Officer

Conference Call Participants

Scott Henry - Roth Capital

Marie Sebalt - BTIG

Bill Maughan - Canaccord Genuity

Yale Jen - Laidlaw & Co

Swayampakula Ramakanth - HC Wainright

Operator

Good morning, and welcome to the Delcath Systems Second Quarter Fiscal 2022 Financial Results Conference Call. All participants’ will be in listen-only mode. [Operator Instructions] After today’s presentation there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.

I’d now like to turn the conference over to David Hoffman, General Counsel of Delcath Systems. Please go ahead.

David Hoffman

Thank you. And once again welcome to Delcath Systems second quarter 2022 earnings call.

With me on the call are Gerard Michel, Chief Executive Officer; Dr. Johnny John, Senior Vice President of Medical Affairs and Clinical Development; Kevin Muir, Vice President of Commercial Operations; John Purpura, Chief Operating Officer, and Anthony Dias, Vice President of Finance.

I'd like to begin the call by reading the Safe Harbor statement. This statement is made pursuant to the Safe Harbor for forward-looking statement described in the Private Securities Litigation Reform Act of 1995. All statements made on this call, with the exception of historical facts, may be considered forward-looking statements within the meaning of Section 27(a) of the Securities Act of 1933 and Section 21(e) of the Securities Exchange Act of 1934. Although the company believes that expectations and assumptions reflected in these forward-looking statements are reasonable, it makes no assurance that such expectations will prove to have been correct. Actual results may differ materially from those expressed or implied in forward-looking statements due to various risks and uncertainties.

For a discussion of such risks and uncertainties which could cause actual results to differ from those expressed or implied in the forward-looking statements, please see Risk Factors detailed in the company’s annual report on Form 10-K, those contained in subsequently filed quarterly reports on Form 10-Q, as well as in other reports that the company files from time-to-time with the Securities and Exchange Commission.

Any forward-looking statements included in this earnings call are made only as of the date of this call. We do not undertake any obligation to update or supplement any forward-looking statements to reflect subsequent knowledge, events or circumstances.